efficacy & tolerability of available tki therapies in cml & managing tki resistance
Published 1 year ago • 60 plays • Length 6:22Download video MP4
Download video MP3
Similar videos
-
2:45
understanding the cause of tki resistance to improve management strategies in cml
-
2:11
addressing the issue of resistance to tkis in cml
-
1:39
emerging therapeutic approaches for tki-resistant cml
-
1:39
cost-benefit considerations for tki selection in cml
-
1:24
considerations for tki choice in frontline and r/r cml
-
3:35
tki-related toxicities in cml & the importance of long-term monitoring
-
2:03
update on the efficacy and safety of tyrosine kinase inhibitors for chronic myeloid leukemia
-
1:04
combining autophagy inhibitors with tkis in cml
-
42:38
t cell analysis fine-tuned to your cells’ needs [webinar]
-
3:52
blood volume monitoring animation - crit-line® technology
-
3:00
hematopathology-myeloid-cml.mp4
-
4:27
cml management in resource limited countries
-
1:22
unmet needs in cml: increasing treatment-free remission & accessibility to tkis
-
2:08
safety, efficacy and tolerability of ide-cel in the real-world
-
4:25
metabolic vulnerabilities in cml & the impact of tkis on glucose anaplerosis
-
3:44
is it possible to reach an operational cure for cml?
-
4:33
optimizing discontinuation of tyrosine kinase inhibitor treatment for chronic myeloid leukemia
-
1:34
destiny update: achieving tfr by de-escalating tki therapy in cml
-
7:27
menin inhibitors in aml: mechanism of action, the current key data, and predicting efficacy
-
2:41
cell avidity as a predictor of t-cell efficacy
-
3:12
balancing efficacy and tolerability in multiple myeloma
-
2:15
safety and efficacy of astx727 in patients with cmml from phase ii and phase iii ascertain studies